Show simple item record

dc.contributor.authorCalderón Domínguez, María 
dc.contributor.authorTrejo Gutiérrez, Eva Lucía 
dc.contributor.authorGonzález Rovira, Almudena 
dc.contributor.authorBeltrán Camacho, Lucía 
dc.contributor.authorRojas Torres, Marta 
dc.contributor.authorEslava Alcón, Sara 
dc.contributor.authorSánchez Morillo, Daniel 
dc.contributor.authorCalderón-Domínguez, Juan
dc.contributor.authorMartinez‑Nicolás, Mª Pilar
dc.contributor.authorGonzalez-Beitia, Estibaliz
dc.contributor.authorNieto-Martín, Mª Dolores
dc.contributor.authorTrujillo-Soto, Teresa
dc.contributor.authorRodríguez Iglesias, Manuel Antonio 
dc.contributor.authorMoreno, Juan A.
dc.contributor.authorMoreno Luna, Rafael
dc.contributor.authorDurán Ruiz, María del Carmen 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.contributor.otherIngeniería en Automática, Electrónica, Arquitectura y Redes de Computadoreses_ES
dc.date.accessioned2023-01-10T13:00:23Z
dc.date.available2023-01-10T13:00:23Z
dc.date.issued2022-09
dc.identifier.issn2162-2531
dc.identifier.urihttp://hdl.handle.net/10498/27709
dc.description.abstractDespite the extraordinary advances achieved to beat COVID-19 disease, many questions remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors determine why individuals respond so differently to the viral infection. Herein, we performed an in silico analysis to identify host microRNA targeting ACE2, TMPRSS2, and/or RAB14, all genes known to participate in viral entry and replication. Next, the levels of six microRNA candidates previously linked to viral and respiratory-related pathologies were measured in the serum of COVID-19-negative controls (n = 16), IgG-positive COVID-19 asymptomatic individuals (n = 16), and critical COVID-19 patients (n = 17). Four of the peripheral micro-RNAs analyzed (hsa-miR-32-5p, hsa-miR-98-3p, hsa-miR-423-3p, and hsa-miR-1246) were upregulated in COVID-19 critical patients compared with COVID-19-negative controls. Moreover, hsa-miR-32-5p and hsa-miR-1246 levels were also altered in critical versus asymptomatic individuals. Furthermore, these microRNA target genes were related to viral infection, inflammatory response, and coagulation-related processes. In conclusion, SARS-CoV-2 promotes the alteration of microRNAs targeting the expression of key proteins for viral entry and replication, and these changes are associated with disease severity. The microRNAs identified could be taken as potential biomarkers of COVID-19 progression as well as candidates for future therapeutic approaches against this disease.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherELSEVIERes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceMolecular Therapy - Nucleic Acids, Vol. 29, pp. 76-87es_ES
dc.titleSerum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patientses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.omtn.2022.06.006


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional